Endogenous Angiotensin II-induced p44/42 Mitogen-Activated Protein Kinase Activation Mediates Sodium Appetite but not Thirst or Neurohypophysial Secretion in Male Rats

Journal of Neuroendocrinology

Volumn 25, Issue 2, 2013, Pages 97-106

  Felgendreger, L A ^a   Fluharty, S J ^a   Yee, D K ^a   Flanagan Cato, L M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Circumventricular organs; Diuresis; Fluid homeostasis; Oxytocin; Vasopressin

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ARGIPRESSIN; CAPTOPRIL; FUROSEMIDE; IRBESARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXYTOCIN;

ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME ACTIVATION; FLUID INTAKE; HORMONE RELEASE; MALE; NEUROHYPOPHYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM APPETITE; SODIUM INTAKE; THIRST;

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; APPETITE; DIURETICS; FUROSEMIDE; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; PITUITARY HORMONES, POSTERIOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; SODIUM, DIETARY; THIRST;

EID: 84873035789     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2012.02376.x     Document Type: Article

References (44)

1. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977; 57: 313-370.
2. Bakris G. Are there effects of renin-angiotensin system antagonists beyond blood pressure control? Am J Cardiol 2010; 105: 21A.
3. Ferguson AV, Washburn DL, Latchford KJ. Hormonal and neurotransmitter roles for angiotensin in the regulation of central autonomic function. Exp Biol Med (Maywood) 2001; 226: 85-96.
4. Geerling JC, Loewy AD. Central regulation of sodium appetite. Exp Physiol 2008; 93: 177-209.
5. Epstein AN, Fitzsimons JT, Rolls BJ. Drinking induced by injection of angiotensin into the rain of the rat. J Physiol 1970; 210: 457-474.
6. Findlay AL, Epstein AN. Increased sodium intake is somehow induced in rats by intravenous angiotnesin II. Horm Behav 1980; 14: 86-92.
7. Marc Y, Llorens-Cortes C. The role of the brain renin-angiotensin system in hypertension: implications for new treatment. Prog Neurobiol 2011; 95: 89-103.
8. Beresford MJ, Fitzsimons JT. Intracerebroventricular angiotensin II-induced thirst and sodium appetite in rat are blocked by the AT1 receptor antagonist, losartan (Dup753), but not by the AT2 antagonist, CGP 42112A. Exp Physiol 1992; 77: 761-764.
9. Alain Enjalbert, Fritz Sladeczek, Gilles Guillon, Philippe Bertrand, Christine Shu, Jacques Epelbaum, Adolph Garcia-Sainz, Serge Jard, Colette Lombard, Claude Kordon and Joel Bockaert. Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. involvement in prolactin secretion. J Biol Chem 1986; 261: 4071-4075.
10. Sadoshima J, Qiu Z, Morgan JP, Izumo S. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. the critical role of Ca(2+)-dependent signaling. Circ Res 1995; 76: 1-15.
11. Clark AJ, Balla T, Jones MR, Catt KJ. Stimulation of early gene expression by angiotensin II in bovine adrenal glomerulosa cells: roles of calcium and protein kinase C. Mol Endocrinol 1992; 6: 1889-1898.
12. Lee MH, El-Shewy HM, Luttrell DK, Luttrell LM. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription. J Biol Chem 2008; 4: 2088-2097.
13. LeHoux JG, Lefebvre A. Novel protein kinase C-epsilon inhibits human CYP11B2 gene expression through ERK1/2 signalling pathway and JunB. J Mol Endocrinol 2006; 36: 51-64.
14. Wei SG, Yu Y, Zhang ZH, Felder RB. Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol 2009; 296: H1425-H1433.
15. Daniels D, Mietlicki EG, Nowak EL, Fluharty SJ. Angiotensin II stimulates water and NaCl intake through separate cell signaling pathways in rats. Exp Physiol 2009; 94: 130-137.
16. Daniels D, Yee DK, Faulconbridge LF, Fluharty SJ. Divergent behavioral roles of angiotensin receptor intracellular signaling cascades. Endocrinology 2005; 146: 5552-5560.
17. Thunhorst RL, Johnson AK. Renin-angiotensin, arterial blood pressure, and salt appetite in rats. Am J Physiol 1994; 2: R458-R465.
18. Chai SY, Allen AM, Adam WR, Mendelsohn FA. Local actions of angiotensin II: quantitative in vitro autoradiographic localization of angiotensin II receptor binding and angiotensin converting enzyme in target tissues. J Cardiovasc Pharmacol 1986; 8 (Suppl 10): S35-S39.
19. Thunhorst RL, Morris M, Johnson AK. Endocrine changes associated with a rapidly developing sodium appetite in rats. Am J Physiol 1994; 2: R1168-R1173.
20. Andersson B, Eriksson L, Fernandez O, Kolmodin CG, Oltner R. Centrally mediated effects of sodium and angiotensin II on arterial blood pressure and fluid balance. Acta Physiol Scand 1972; 85: 398-407.
21. Conrad KP, Gellai M, North WG, Valtin H. Influence of oxytocin on renal hemodynamics and sodium excretion. Ann NY Acad Sci 1993; 689: 346-362.
22. Stricker EM, Verbalis JG. Central inhibition of salt appetite by oxytocin in rats. Regul Pept 1996; 2: 83-85.
23. Ganong WF. The renin-angiotensin system and the central nervous system. Fed Proc 1977; 36: 1771-1775.
24. McKinley MJ, Allen AM, Burns P, Colvill LM, Oldfield BJ. Interaction of circulating hormones with the brain: the roles of the subfornical organ and the organum vasculosum of the lamina terminalis. Clin Exp Pharmacol Physiol Suppl 1998; 25: S61-S67.
25. Khan AM, Watts AG. Intravenous 2-deoxy-D-glucose injection rapidly elevates levels of the phosphorylated forms of p44/42 mitogen-activated protein kinases (extracellularly regulated kinases 1/2) in rat hypothalamic parvicellular paraventricular neurons. Endocrinology 2004; 145: 351-359.
26. Verbalis JG, McHale CM, Gardiner TW, Stricker EM. Oxytocin and vasopressin secretion in response to stimuli producing learned taste aversions in rats. Behav Neurosci 1986; 100: 466-475.
27. Gohlke P, Kox T, Jurgensen T, Von Kugelgen S, Rascher W, Unger T, Culman J. Peripherally applied candesartan inhibits central responses to angiotensin II in conscious rats. Naunyn Schmiedeberg's Arch Pharmacol 2002; 365: 477-483.
28. Hines J, Fluharty SJ, Yee DK. Structural determinants for the activation mechanism of the angiotensin II type 1 receptor differ for phosphoinositide hydrolysis and mitogen-activated protein kinase pathways. Biochem Pharmacol 2003; 66: 251-262.
29. Reis WL, Saad WA, Camargo LA, Elias LL, Antunes-Rodrigues J. Central nitrergic system regulation of neuroendocrine secretion, fluid intake and blood pressure induced by angiotensin-II. Behav Brain Funct 2010; 6: 64.
30. Fitzsimons JT, Stricker EM. Sodium appetite and the renin-angiotensin system. Nat New Biol 1971; 231: 58-60.
31. Renaud LP, Bourque CW. Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin. Prog Neurobiol 1991; 36: 131-169.
32. Roesch DM, Blackburn-Munro RE, Verbalis JG. Mineralocorticoid treatment attenuates activation of oxytocinergic and vasopressinergic neurons by icv ANG II. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1853-R1864.
33. Keil LC, Rosella-Dampman LM, Emmert S, Chee O, Summy-Long JY. Enkephalin inhibition of angiotensin-stimulated release of oxytocin and vasopressin. Brain Res 1984; 297: 329-336.
34. Schrader LA, Birnbaum SG, Nadin BM, Ren Y, Bui D, Anderson AE, Sweatt JD. ERK/MAPK regulates the Kv4.2 potassium channel by direct phosphorylation of the pore-forming subunit. Am J Physiol Cell Physiol 2006; 290: C852-C861.
35. Numakawa T, Yokomaku D, Kiyosue K, Adachi N, Matsumoto T, Numakawa Y, Taguchi T, Hatanaka H, Yamada M. Basic fibroblast growth factor evokes a rapid glutamate release through activation of the MAPK pathway in cultured cortical neurons. J Biol Chem 2002; 277: 28861-28869.
36. Schenk U, Menna E, Kim T, Passafaro M, Chang S, De Camilli P, Matteoli M. A novel pathway for presynaptic mitogen-activated kinase activation via AMPA receptors. J Neurosci 2005; 25: 1654-1663.
37. Olsen MK, Reszka AA, Abraham I. KT5720 and U-98017 inhibit MAPK and alter the cytoskeleton and cell morphology. J Cell Physiol 1998; 176: 525-536.
38. Swank MW, Sweatt JD. Increased histone acetyltransferase and lysine acetyltransferase activity and biphasic activation of the ERK/RSK cascade in insular cortex during novel taste learning. J Neurosci 2001; 21: 3383-3391.
39. Roitman MF, Na E, Anderson G, Jones TA, Bernstein IL. Induction of a salt appetite alters dendritic morphology in nucleus accumbens and sensitizes rats to amphetamine. J Neurosci 2002; 22: RC225.
40. Wei SG, Yu Y, Zhang ZH, Weiss RM, Felder RB. Angiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats. Hypertension 2008; 52: 342-350.
41. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis 2006; 49: 59-75.
42. Del Giudice A, Pompa G, Aucella F. Hypertension in the elderly. J Nephrol 2010; 23(Suppl 15): S61-S71.
43. Margolius D, Bodenheimer T. Controlling hypertension requires a new primary care model. Am J Manag Care 2010; 16: 648-650.
44. Felder RB, Yu Y, Zhang ZH, Wei SG. Pharmacological treatment for heart failure: a view from the brain. Clin Pharmacol Ther 2009; 86: 216-220.